Related by context. Frequent words. (Click for all words.) 64 Pivotal Phase III 63 Phase III Clinical Trial 63 Single Dose 63 Metastatic Melanoma 63 Patient Enrollment 62 Phase III Trial 62 Pivotal Study 62 refractory chronic lymphocytic 62 Pivotal Phase 62 Clinical Trial Results 61 Panzem R 61 Initiate Phase 61 Drug Candidate 61 Pivotal Trial 59 Benign Prostatic Hyperplasia 59 MKC# 58 Diabetic Macular Edema 58 forodesine 58 Denufosol 58 luteinizing hormone releasing 58 Significantly Reduces 57 II Clinical Trial 57 BrachySil 57 Well Tolerated 57 ATL# [001] 57 Thrombin 57 VALSTAR 57 Microplasmin 57 ThermoDox R 57 Pulmonary Arterial Hypertension 57 Monotherapy 57 elotuzumab 57 Amrubicin 57 Low Dose 56 Eculizumab 56 Cancer Vaccines 56 Bicifadine 56 Epratuzumab 56 Gastric Cancer 56 Azedra 56 Factor VIIa 55 Proxinium TM 55 Atopic Dermatitis 55 Confirmatory 55 Reduces Risk 55 murine model 55 Ixempra 55 phase IIb clinical 55 Daclizumab 55 AMD# [002] 54 metastatic hormone refractory 54 Phase IIB 54 Combination Therapy 54 GRNVAC1 54 Cloretazine R VNP#M 54 Thiarabine 54 Fibrillex TM 54 R sorafenib tablets 54 Patients Treated 54 Phase Ib II 54 Study Demonstrates 53 MOZOBIL 53 multicenter Phase 53 Octreotide 53 PEGPH# 53 Virulizin R 53 Mipomersen 53 squalamine 53 ApoB SNALP 53 multiple myeloma MM 53 ICA # 53 OMS#HP 53 ONTAK 52 phase IIa clinical 52 Phase Ib clinical 52 Nexavar ® 52 Allovectin 7 R 52 AEG# 52 Vfend 52 ferric citrate 52 Aurexis 51 drug eluting coronary stent 51 MEK inhibitor 51 Chrysalin 51 EndoTAG TM -1 51 Paraplatin 51 TH# [003] 51 mTOR inhibitor 51 dirucotide 51 cintredekin besudotox 51 GGF2 51 Telcyta 51 IPLEX 51 Allergic Rhinitis 51 MAXY G# 51 leuprolide acetate 51 Extended Release 51 Patient Outcomes 51 Shows Promise 50 Urokinase 50 TACI Ig